Docket: 02N-0115 - Risk Management of Prescription Drugs; Public Hearing
Registration Number: EAPE -4
Accepted - Volume 2
Registration for Risk Management of Prescription Drugs; Public Hearing
Dr. Diana Zuckerman
Nat. Ctr. for Policy Research for Women & Families
1. Brief statement of the general nature of the views you wish to present.
The Importance of Post-Market Surveillance and Studies
2. The names and addresses of all persons who will participate in the presentation.
Dr. Diana Zuckerman 1901 Pennsylvania Avenue, Suite 901 Washington, DC 20006
3. Approximate time that you request to make your presentation.